Boehringer Ingelheim animal health sales triples after merger

The Six months upon completion of the merger with Merial, maker of parasiticide for dogs and cats, Frontline, Boehringer Ingelheim has seen sales of your triple their built-up land area of animal health globally, to 2.1 billion euros. The idea is to get the company to world leadership in the animal health market, which covers not only pets, but the whole universe related to livestock production. In Brazil, Boehringer Ingelheim has factories in Itapecerica da Serra and Paulínia, in the State of São Paulo, with a focus on products for human and animal health, respectively.